{"id":"https://openalex.org/W2959529376","doi":"https://doi.org/10.1200/jco.2019.37.8_suppl.123","title":"Healthcare provider awareness and integration of immunotherapy for stage III NSCLC.","display_name":"Healthcare provider awareness and integration of immunotherapy for stage III NSCLC.","publication_year":2019,"publication_date":"2019-03-10","ids":{"openalex":"https://openalex.org/W2959529376","doi":"https://doi.org/10.1200/jco.2019.37.8_suppl.123","mag":"2959529376"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2019.37.8_suppl.123","doi":"https://doi.org/10.1200/jco.2019.37.8_suppl.123","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.8_suppl.123","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030740396","display_name":"Rachael M. Andrie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachael Andrie","raw_affiliation_strings":["Clinical Care Options, LLC, Reston, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Care Options, LLC, Reston, VA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089950983","display_name":"Timothy A. Quill","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy A. Quill","raw_affiliation_strings":["Clinical Care Options, LLC, Reston, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Care Options, LLC, Reston, VA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046938066","display_name":"Angelique Vinther","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angelique Vinther","raw_affiliation_strings":["Clinical Care Options, LLC, Reston, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Care Options, LLC, Reston, VA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041355641","display_name":"T Stacy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tina B. Stacy","raw_affiliation_strings":["Clinical Care Options, LLC, Reston, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Care Options, LLC, Reston, VA;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006520731","display_name":"Kevin L Obholz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin Obholz","raw_affiliation_strings":["Clinical Care Options, LLC, Reston, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Care Options, LLC, Reston, VA;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":"8_suppl","first_page":"123","last_page":"123"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8413000106811523,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8413000106811523,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.13259999454021454,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.010300000198185444,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":0.8389999866485596},{"id":"https://openalex.org/keywords/stage-iii-non-small-cell-lung-cancer","display_name":"stage III NSCLC","score":0.8930000066757202},{"id":"https://openalex.org/keywords/unresectable-nsclc","display_name":"unresectable NSCLC","score":0.8090000152587891},{"id":"https://openalex.org/keywords/concurrent-chemoradiotherapy","display_name":"concurrent chemoradiotherapy","score":0.7889999747276306},{"id":"https://openalex.org/keywords/pd-l1-blockade","display_name":"PD-L1 blockade","score":0.8320000171661377},{"id":"https://openalex.org/keywords/consolidation-therapy","display_name":"consolidation therapy","score":0.8379999995231628},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.5590000152587891},{"id":"https://openalex.org/keywords/physician-awareness","display_name":"physician awareness","score":0.5910000205039978},{"id":"https://openalex.org/keywords/guideline-adherence","display_name":"guideline adherence","score":0.421999990940094},{"id":"https://openalex.org/keywords/managed-care-pharmacy","display_name":"managed care pharmacy","score":0.6230000257492065},{"id":"https://openalex.org/keywords/continuing-medical-education","display_name":"continuing medical education","score":0.8510000109672546}],"concepts":[{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.9520076513290405},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.872201681137085},{"id":"https://openalex.org/C2780182762","wikidata":"https://www.wikidata.org/wiki/Q1630279","display_name":"Guideline","level":2,"score":0.48254507780075073},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4086993932723999},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3733397424221039},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3402974009513855},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3245842456817627},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.30808109045028687},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.14327359199523926},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08445844054222107}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2019.37.8_suppl.123","doi":"https://doi.org/10.1200/jco.2019.37.8_suppl.123","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.8_suppl.123","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2909427482","https://openalex.org/W3208741112","https://openalex.org/W4390988944","https://openalex.org/W3026834933","https://openalex.org/W2981784723","https://openalex.org/W7164383300","https://openalex.org/W4404690297","https://openalex.org/W3172491632","https://openalex.org/W3158014526","https://openalex.org/W3216085279"],"abstract_inverted_index":{"123":[0],"Background:":[1],"In":[2],"February":[3],"2018,":[4],"immunotherapy":[5,246],"was":[6,113],"approved":[7,114],"for":[8,75,160,247],"patients":[9,76],"with":[10,60,77,165,210],"unresectable":[11,78,248],"stage":[12,79,166,249],"III":[13,80,167,250],"NSCLC":[14,168],"without":[15],"progression":[16],"after":[17,111,169],"concurrent":[18],"chemoradiotherapy":[19],"(cCRT).":[20],"The":[21],"anti\u2013PD-L1":[22],"inhibitor":[23],"durvalumab":[24,73,112,157,192,211],"is":[25],"now":[26],"considered":[27],"by":[28],"most":[29],"experts":[30],"to":[31,55,119],"be":[32],"the":[33,69,145,184,202,235,243],"standard":[34],"of":[35,51,72,123,153,188,191,205,228,234,245],"care":[36,99],"(SoC)":[37],"in":[38,242],"this":[39],"setting":[40],"based":[41,194],"on":[42,68,148,178,195],"improved":[43],"survival":[44],"outcomes.":[45],"Methods:":[46],"We":[47],"conducted":[48,85],"a":[49,225],"series":[50],"5":[52,146],"CME-certified":[53],"symposia":[54,83],"provide":[56],"healthcare":[57],"providers":[58],"(HCPs)":[59],"education":[61],"that":[62,224],"included":[63],"expert":[64],"and":[65,96,126,134,239],"guideline":[66],"recommendations":[67],"optimal":[70,185,203],"use":[71],"therapy":[74,159,193],"NSCLC.":[81,251],"These":[82,220],"were":[84,129,136],"at":[86,131],"3":[87],"major":[88],"oncology":[89],"conferences":[90,102],"(NCCN":[91],"Annual,":[92,104],"AACR,":[93],"ASCO":[94],"Annual)":[95],"2":[97],"managed":[98],"pharmacy":[100],"(MCP)":[101],"(AMCP":[103],"AMCP":[105],"Nexus)":[106],"over":[107],"an":[108,139,161],"8-month":[109],"period":[110],"(Table).":[115,171,218],"Polling":[116],"questions":[117],"designed":[118],"assess":[120],"key":[121],"aspects":[122],"HCP":[124],"knowledge":[125],"practice":[127],"patterns":[128],"repeated":[130],"each":[132],"symposium":[133],"responses":[135],"collected":[137],"through":[138],"audience":[140],"response":[141],"system.":[142],"Results:":[143],"Across":[144],"symposia,":[147,177],"average":[149,179],"fewer":[150,180],"than":[151,181,215],"45%":[152],"responding":[154,173],"HCPs":[155,174,217,229],"recommended":[156,186],"consolidation":[158],"ideal":[162],"patient":[163],"candidate":[164],"cCRT":[170],"Among":[172],"across":[175],"4":[176],"30%":[182],"identified":[183],"duration":[187],"1":[189],"year":[190],"current":[196],"clinical":[197,237],"evidence.":[198],"Physicians":[199],"did":[200],"identify":[201],"management":[204],"immune-related":[206],"pulmonary":[207],"toxicity":[208],"associated":[209],"treatment":[212],"more":[213],"often":[214],"other":[216],"Conclusions:":[219],"pre-education":[221],"data":[222],"suggest":[223],"large":[226],"percentage":[227],"are":[230,240],"not":[231],"fully":[232],"aware":[233],"available":[236],"evidence":[238],"delayed":[241],"implementation":[244],"[Table:":[252],"see":[253],"text]":[254]},"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2019-07-23T00:00:00"}